These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7743676)

  • 1. Immunodeficiency in RFM/(T6xRFM)F1 mouse chimaeras with lethal host-versus-graft syndrome.
    Hard RC; Montour JL; Fuchs BA
    Clin Exp Immunol; 1995 May; 100(2):352-8. PubMed ID: 7743676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfractionated spleen cells but not natural killer (NK) cells from RFM donors prevent the progression of host-versus-graft disease in murine RFM/(T6 x RFM)F1 chimeras.
    Hard RC; Patel MR; Keller LM; Linna TJ
    Immunology; 1988 Mar; 63(3):457-64. PubMed ID: 3258280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitized (T6 x RFM)F1 donor B cells contribute to hypergammaglobulinemia and to poor primary responses in RFM mice with allogenic host versus graft disease.
    Hard RC; Benson LL
    Cell Immunol; 1986 Sep; 101(2):593-603. PubMed ID: 3489542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease.
    Hard RC; Carter WH; Bick PH
    J Immunol; 1983 Dec; 131(6):2623-9. PubMed ID: 6358351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.
    Hard RC
    Clin Exp Immunol; 1975 Nov; 22(2):330-40. PubMed ID: 1082403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.
    Cross SS; Brede G; Tucker HS; Maloney M; Montour JL; Hard RC
    Infect Immun; 1983 Aug; 41(2):570-7. PubMed ID: 6135664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment of allogeneic hematopoietic stem cells requires both inhibition of host-versus-graft responses and 'space' for homeostatic expansion.
    Laylor R; Dewchand H; Simpson E; Dazzi F
    Transplantation; 2005 Jun; 79(11):1484-91. PubMed ID: 15940036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent difference in the roles of spleen and lymph nodes in the pathogenesis of host-versus-graft disease in murine parent/F1 chimeras.
    Hard RC; Benson LL; Keller LM
    Transplantation; 1987 Sep; 44(3):434-9. PubMed ID: 3498242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal immunopathology in murine host-versus-graft disease.
    Florquin S; Abramowicz D; de Heer E; Bruijn JA; Doutrelepont JM; Goldman M; Hoedemaeker P
    Kidney Int; 1991 Nov; 40(5):852-61. PubMed ID: 1762289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong T cell tolerance in parent----F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy.
    Gao EK; Lo D; Sprent J
    J Exp Med; 1990 Apr; 171(4):1101-21. PubMed ID: 2139098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions.
    Murphy WJ; Bennett M; Anver MR; Baseler M; Longo DL
    Eur J Immunol; 1992 Jun; 22(6):1421-7. PubMed ID: 1534757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of the T cell deficiency in RFM mice with host versus graft disease.
    Hard RC; Campbell RC
    Cell Immunol; 1979 Mar; 43(2):225-34. PubMed ID: 157816
    [No Abstract]   [Full Text] [Related]  

  • 15. Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.
    Van Elven EH; Rolink AG; Veen FV; Gleichmann E
    J Exp Med; 1981 Jun; 153(6):1474-88. PubMed ID: 6454750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
    Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic studies of RFM mice which are susceptible to host versus graft disease following the perinatal inoculations of (T6 x RFM)F1 spleen cells and of T6T6 mice which are not.
    Hard RC; Cross SS; Brede G; Montour JL; Carter WH
    Clin Immunol Immunopathol; 1981 Sep; 20(3):427-35. PubMed ID: 6978788
    [No Abstract]   [Full Text] [Related]  

  • 18. Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.
    Gorczynski RM; Macrae S
    Immunology; 1981 Dec; 44(4):827-46. PubMed ID: 6172375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.